NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacology and therapeutics - 52(2014), 1 vom: 07. Jan., Seite 92-4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mader, Robert M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 2.7.10.1 |
|---|
| Anmerkungen: |
Date Completed 10.04.2014 Date Revised 03.12.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.5414/CPXCES13EA08 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM232546665 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM232546665 | ||
| 003 | DE-627 | ||
| 005 | 20231224093225.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5414/CPXCES13EA08 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0775.xml |
| 035 | |a (DE-627)NLM232546665 | ||
| 035 | |a (NLM)24219969 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mader, Robert M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NSCLC cells adapted to EGFR inhibition accumulate EGFR interacting proteins and down-regulate microRNA related to epithelial-mesenchymal transition |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.04.2014 | ||
| 500 | |a Date Revised 03.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a MicroRNAs |2 NLM | |
| 650 | 7 | |a ErbB Receptors |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Foerster, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Sarin, Navin |e verfasserin |4 aut | |
| 700 | 1 | |a Michaelis, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Cinatl, Jindrich |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Kloft, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Fröhlich, Holger |e verfasserin |4 aut | |
| 700 | 1 | |a Engel, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Kalayda, Ganna V |e verfasserin |4 aut | |
| 700 | 1 | |a Jäger, Walter |e verfasserin |4 aut | |
| 700 | 1 | |a Frötschl, Roland |e verfasserin |4 aut | |
| 700 | 1 | |a Jaehde, Ulrich |e verfasserin |4 aut | |
| 700 | 1 | |a Ritter, Christoph A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacology and therapeutics |d 1997 |g 52(2014), 1 vom: 07. Jan., Seite 92-4 |w (DE-627)NLM075091739 |x 0946-1965 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2014 |g number:1 |g day:07 |g month:01 |g pages:92-4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5414/CPXCES13EA08 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2014 |e 1 |b 07 |c 01 |h 92-4 | ||